Presidio Medical, Inc., a clinical-stage company focused on developing a groundbreaking neuromodulation platform, is excited to announce the appointment of Richard J. Buchholz to its Board of Directors. Rick currently serves as the Chief Financial Officer at Inspire Medical Systems, Inc. (NYSE: INSP), where he has been instrumental in driving strategic financial and operational growth for the global leader in innovative, minimally invasive solutions for patients with obstructive sleep apnea.
Presidio Medical, Inc., a clinical-stage company focused on developing a transformational neuromodulation platform, is pleased to announce that Richard J. Buchholz will be joining its Board of Directors. This appointment comes at a pivotal moment in the company’s journey, and leadership is confident that Mr. Buchholz’s expertise will play a crucial role in Presidio’s next phases of growth.
“We are excited that Rick is joining the Board of Directors of Presidio Medical at this critical time in our company’s journey. His leadership and financial acumen will be instrumental in advancing our vision through key growth and development stages,” said Michael Onuscheck, Chairman and CEO of Presidio Medical.
“I am excited to join the Board as an independent Director and work with the entire team through the next phases of the company’s development,” said Mr. Buchholz. “Presidio Medical’s vision of revolutionizing the way neuromodulation balances the human nervous system—enabling people to live their best life—aligns with my passion for bringing innovative technologies to market that could profoundly impact patient care.”
Mr. Buchholz has a wealth of experience in the medical technology sector. Since 2014, he has served as the Chief Financial Officer of Inspire Medical Systems, Inc., a leader in the development of innovative solutions for patients with obstructive sleep apnea. Under his leadership, Inspire has seen significant strategic and financial growth. Before joining Inspire, Mr. Buchholz held the role of Chief Financial Officer at superDimension, Ltd., from 2006 until its acquisition by Covidien plc in 2013. He also served as the Chief Financial Officer at Vascular Solutions, Inc., which was later acquired by Teleflex Incorporated.
Mr. Buchholz holds a Bachelor of Business Administration (B.B.A.) degree from the University of Wisconsin, Eau Claire, and is a Certified Public Accountant (inactive).
Rick’s appointment to Presidio Medical’s Board of Directors highlights the company’s commitment to securing top-tier leadership to drive its strategic goals. His extensive experience will help accelerate the adoption of Presidio’s innovative neuromodulation solutions and support its mission to transform patient care through cutting-edge technologies.
Founded in 2017 and headquartered in San Mateo, CA, Presidio Medical is a privately held clinical-stage medical device company. The company is developing a neuromodulation platform aimed at treating diseases associated with undesired neural activity, with its first indication focusing on chronic pain. Presidio’s investors include Deerfield Management, Invus Opportunities, Action Potential Venture Capital, and ShangBay Capital.
